Friday, June 05, 2020 1:21:44 AM
8k on 6/1/20 ($4 Buyout Offer Turned Down)
This is what i found on form 25
Understanding SEC Form 25
Securities may be delisted from an exchange for various reasons. Bonds may have matured, been called, or redeemed by a company. A company might want to go private by paying cash for all or a substantial portion of its public shares, or perhaps its outstanding securities have been exchanged for cash or another security as part of a takeover. It might just want to voluntarily delist from a national securities exchange or inter-dealer quotation system, in order to suspend or reduce the company’s public reporting obligations under the Exchange Act.
D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.
Recent SRTS News
- Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024 • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024 • GlobeNewswire Inc. • 04/18/2024 08:05:00 PM
- Sensus Healthcare to Participate in the 36th Annual Roth Conference • GlobeNewswire Inc. • 03/14/2024 08:05:00 PM
- Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:15:59 PM
- Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/08/2024 09:05:57 PM
- Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities • GlobeNewswire Inc. • 02/08/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 05:27:47 PM
- Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements • GlobeNewswire Inc. • 02/06/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:00:38 PM
- Sensus Healthcare Announces Retirement of Director Samuel O’Rear • GlobeNewswire Inc. • 02/01/2024 01:00:00 PM
- Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024 • GlobeNewswire Inc. • 01/30/2024 01:00:00 PM
- Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million • GlobeNewswire Inc. • 01/23/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:00:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 06:35:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 06:29:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:22:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:07:43 PM
- Sensus Healthcare Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/09/2023 09:05:36 PM
- Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023 • GlobeNewswire Inc. • 11/02/2023 12:00:00 PM
- Sensus Healthcare to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference • GlobeNewswire Inc. • 10/09/2023 12:00:00 PM
- Sensus Healthcare Sells Superficial Radiotherapy System to Cape Cod Hospital • GlobeNewswire Inc. • 09/28/2023 12:30:00 PM
- Sensus Healthcare to Showcase its Full Line of Cutting-Edge Superficial Radiotherapy Devices for the Treatment of Non-melanoma Skin Cancer at ASTRO 2023 in San Diego • GlobeNewswire Inc. • 09/26/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 08:01:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/28/2023 06:27:58 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM